Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

XIII.a

Pulmonary embolism - Venous thrombosis/thrombo-embolism

Acute/chronic. Due to the high background incidence rate of naturally-occurring VTE, a cause-and-effect relationship with drugs or procedures may be difficult to establish firmly. Epidemiologic studies can be supportive (PMID 25924683). A search for antiphospholipid antibodies is indicated. Chronic iatrogenic thromboembolism, for instance in patients with cardiac wires and leads may cause thromboembolic pulmonary hypertension (PMID 24881082)

Publications

Ma JY, Chuang CH

A 54-Year-Old Man With Migratory Pulmonary Consolidation and Progressive Dyspnea.

Chest 2022 Aug;162;e85-e88 — 2022 Aug — e85-e88

Mahgoub AE, Awuah D, Hussain M, Deliwala S, Bachuwa G, Younas M

Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation.

Cureus 2022 Feb;14;e22179 — 2022 Feb — e22179

Vallone MG, Falcón AL, Castro HM, Ferraris A, Cantarella RF, Staneloni MI, Aliperti VI, Ferloni A, Mezzarobba D, Vázquez FJ, Ratti MFG

Thrombotic events following Covid-19 vaccines compared to Influenza vaccines.

European journal of internal medicine 2022 Mar 09;; — 2022 Mar 09

Curcio R, Gandolfo V, Alcidi R, Giacomino L, Campanella T, Casarola G, Rossi R, Chiatti L, D'Abbondanza M, Commissari R, Gresele P, Pucci G, Vaudo G

Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022 Jan 02;116;154-156 — 2022 Jan 02 — 154-156

Tobaiqy M, MacLure K, Elkout H, Stewart D

Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.

Vaccines 2021 Nov 15;9; — 2021 Nov 15

Wiest NE, Johns GS, Edwards E

A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization.

Vaccines 2021 Aug 14;9; — 2021 Aug 14

Al-Maqbali JS, Al Rasbi S, Kashoub MS, Al Hinaai AM, Farhan H, Al Rawahi B, Al Alawi AM

A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.

The American journal of case reports 2021 Jun 12;22;e932946 — 2021 Jun 12 — e932946

Esba LCA, Al Jeraisy M

Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST).

Expert review of vaccines 2021 Jun 17;;1-6 — 2021 Jun 17 — 1-6

Carli G, Nichele I, Ruggeri M, Barra S, Tosetto A

Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine.

Internal and emergency medicine 2021 04;16;803-804 — 2021 04 — 803-804